Sarah de Ferranti (Boston Children’s) led a study that suggests twice as many people as previously thought are genetically predisposed to develop dangerously high cholesterol levels.
Additional coverage:
The Boston Globe (via Bloomberg News)
Sarah de Ferranti (Boston Children’s) led a study that suggests twice as many people as previously thought are genetically predisposed to develop dangerously high cholesterol levels.
Additional coverage:
The Boston Globe (via Bloomberg News)
